Litcius/Paper detail

Autologous bone marrow-derived mesenchymal stromal cell therapy with early tacrolimus withdrawal: The randomized prospective, single-center, open-label TRITON study

Marlies E. J. Reinders, Koen E. Groeneweg, Sanne H. Hendriks, Jonna R. Bank, Geertje J. Dreyer, Aiko P. J. de Vries, Melissa van Pel, Helene Roelofs, Volkert A.L. Huurman, Paula Meij, Dirk Jan A. R. Moes, Willem E. Fibbe, Frans H.J. Claas, Dave L. Roelen, Cees van Kooten, Jesper Kers, Sebastiaan Heidt, Ton J. Rabelink, Johan W. de Fijter

2021American Journal of Transplantation38 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTacrolimusMesenchymal stem cellOpen labelSingle CenterBone marrowRandomized controlled trialStromal cellSurgeryInternal medicineTransplantationPathologyMesenchymal stem cell researchTissue Engineering and Regenerative MedicineHematopoietic Stem Cell Transplantation